Collegium Pharmaceutical, Inc. vs. Purdue Pharma L.P. et al.
Explore the PTAB proceeding PGR2018-00048 filed by Collegium Pharmaceutical, Inc. on 2018-03-13. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2018-00048
Filing Date
2018-03-13
Accorded Filing Date
2018-04-11
Institution Decision Date
2018-10-04
Last Modified Date
2024-03-18
Proceeding Type
PGR
Termination Date
2021-11-19
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Collegium Pharmaceutical, Inc.
Represented By
Morton, Cyruset alPatent Owner / Respondent
Purdue Pharma L.P. et al.
Represented By
Hendler, Pabloet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 31375 | Richard Inz | +1 718-744-8243 |
| 32937 | Karin Russo | +1 203-241-3471 |
| 34258 | Philip Strassburger | +1 203-434-6405 |
| 34848 | Mark Kesslen | +1 973-597-2500 |
| 37371 | Alan Koller | +1 203-249-6230 |
| 40538 | Stephen Buckingham | +1 973-597-2326 |
| 41240 | Robert Paradiso | +1 973-597-2404 |
| 41717 | James Doyle | +1 401-595-2834 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,693,961 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2017029653 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019011099 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 31,053,401 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2003006837 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,389,007 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,040,084 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,308,170 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,999,961 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,867,783 B2 | US Continuation / Sibling | View Official Patent → |
Acura Pharmaceuticals, Inc. et al. v. Purdue Pharma L.P. et al.